Literature DB >> 22714753

Epidemiological profile of leprosy in the Brazilian state of Piauí between 2003 and 2008.

Manoel Wilkley Gomes de Sousa1, Darline Carvalho Silva, Lucianna Rodrigues Carneiro, Maria Luisa Brito Ferreira Almino, Ana Lúcia França da Costa.   

Abstract

BACKGROUND: Leprosy is a chronic infectious disease caused by Mycobacterium leprae. It is considered a major public health issue in developing countries.
OBJECTIVES: To evaluate the clinical and epidemiological profile of leprosy patients between 2003 and 2008 in the state of Piauí, to analyze detection and prevalence rates in the general population and in the population of children under 15 years of age, and to evaluate the predominant clinical forms.
METHODS: Data were obtained from the notifiable diseases database of the State Health Department, Piauí, Brazil. Medical records are retrieved from patients' charts using a specific questionnaire and the collected data is then entered into the database system.
RESULTS: Of the 12,238 cases of leprosy reported in this period, 85% represented new cases. The mean overall annual detection rate was 54 cases/100,000 habitants. The rate for children under 15 years of age was 15.3 cases/100,000 habitants. Overall, 52.18% of the patients were male; 64.66% were between 20 and 59 years of age; and 53.53% had the paucibacillary form of leprosy. Nevertheless, in 88.82% of cases of the paucibacillary form of the disease, more than five lesions were present, while in 10.55% of cases of the multibacillary form of the disease, no lesions were present. Over 20% of patients had some degree of disability.
CONCLUSION: These indicators point to a high circulation of bacilli in the community and highlight the extreme difficulty experienced by the primary healthcare network in organizing itself in order to ensure that patients with this complex disease receive an accurate and early diagnosis.

Entities:  

Mesh:

Year:  2012        PMID: 22714753     DOI: 10.1590/s0365-05962012000300006

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN: 0365-0596            Impact factor:   1.896


  5 in total

1.  Leprosy incidence, characterization of cases and correlation with household and cases variables of the Brazilian states in 2010.

Authors:  Shamyr Sulyvan de Castro; Juliana Pereira Pontes Santos; Graziela Basílio Abreu; Vanessa Rossato Oliveira; Luciane Fernanda Rodrigues Martinho Fernandes
Journal:  An Bras Dermatol       Date:  2016 Jan-Feb       Impact factor: 1.896

2.  Patients' perceptions on the performance of a local health system to eliminate leprosy,Paraná State, Brazil.

Authors:  Flávia Meneguetti Pieri; Michelle Mosna Touso; Ludmila Barbosa Bandeira Rodrigues; Mellina Yamamura; Ione Carvalho Pinto; Elma Mathias Dessunti; Juliane de Almeida Crispim; Antônio Carlos Vieira Ramos; Luiz Henrique Arroyo; Marcelino Santos Neto; Maria Concebida da Cunha Garcia; Marcela Paschoal Popolin; Tatiane Ramos dos Santos Silveira; Ricardo Alexandre Arcêncio
Journal:  PLoS Negl Trop Dis       Date:  2014-11-20

3.  Leprosy in children under 15 years of age in Brazil: A systematic review of the literature.

Authors:  Michelle Christini Araújo Vieira; Joilda Silva Nery; Enny S Paixão; Kaio Vinicius Freitas de Andrade; Gerson Oliveira Penna; Maria Glória Teixeira
Journal:  PLoS Negl Trop Dis       Date:  2018-10-02

4.  Deformities due to Leprosy in Children under Fifteen Years Old as an Indicator of Quality of the Leprosy Control Programme in Brazilian Municipalities.

Authors:  Francisco Carlos Félix Lana; Angélica da Conceição Oliveira Coelho Fabri; Fabiana Nascimento Lopes; Ana Paula Mendes Carvalho; Fernanda Moura Lanza
Journal:  J Trop Med       Date:  2013-03-19

5.  Clinical oxidative stress during leprosy multidrug therapy: impact of dapsone oxidation.

Authors:  Taysa Ribeiro Schalcher; Rosivaldo S Borges; Michael D Coleman; João Batista Júnior; Claudio G Salgado; Jose Luiz F Vieira; Pedro R T Romão; Fabio R Oliveira; Marta Chagas Monteiro
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.